Investigating how cannabis use affects anxiety and coping during stressful times.
Exploring the antecendents and consequences of cannabis use in the context of coping: An experimental study
This study is looking at how using cannabis might help people manage their anxiety, especially during stressful times like the COVID-19 pandemic, and it wants to find out if people tend to use more cannabis when they're feeling stressed and how it affects their stress levels.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-10808782 on NIH RePORTER |
What this research studies
This research explores the relationship between cannabis use and coping with anxiety, particularly in the context of stress exacerbated by the COVID-19 pandemic. It aims to experimentally test whether individuals increase their cannabis consumption when using it to cope with stress and to identify factors that may influence this behavior, such as social anxiety. Additionally, the study will examine if cannabis use effectively reduces stress and the biological mechanisms involved, particularly focusing on the endocannabinoid system. By understanding these dynamics, the research seeks to inform better approaches to cannabis use for anxiety management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing anxiety or stress, particularly those who may be using cannabis as a coping mechanism.
Not a fit: Patients who do not use cannabis or do not experience anxiety or stress may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing anxiety and stress through informed cannabis use.
How similar studies have performed: Previous research has shown varying results regarding the effects of cannabis on anxiety, indicating that this area is still being explored and holds potential for new insights.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Skrzynski, Carillon Joy — University of Colorado
- Study coordinator: Skrzynski, Carillon Joy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.